학술논문
Low dose Rituximab for pre-emptive treatment of Epstein Barr virus reactivation after allogenic hematopoietic stem cell transplantation
Document Type
Article
Author
Source
In Current Research in Translational Medicine November 2019 67(4):145-148
Subject
Language
ISSN
2452-3186